Results 221 to 230 of about 86,485 (257)

Dual Inhibition of TNF-α and IL-6R mitigates cytokine release syndrome via protection of endothelial integrity and reduction of organ damage in mouse models. [PDF]

Front Immunol
Won H, Park E, Roh YG, Kang M, Kim N.
europepmc   +1 more source

Impact of Severe COVID‐19 on Interstitial Lung Disease in Autoimmune Systemic Diseases

Respirology Case Reports, Volume 14, Issue 9, September 2026.
In this multicentre case series of 27 patients with autoimmune systemic diseases, severe COVID‐19 pneumonia led to marked interstitial lung disease (ILD) worsening, with new‐onset or progressive ILD in all survivors and NSIP‐to‐UIP transition in six cases.
Clodoveo Ferri, Marco de Pinto, Giuseppe Murdaca, Giacomo De Luca, Davide Mohammad Reza Beigi, Virginia Caira, Roberta Foti, Andrea Cito, Caterina Naclerio, Jessica Maria Elisa Luppino, Amelia Spinella, Martina Orlandi, Veronica Batani, Federica Lumetti, Francesco Prampolini, Giuseppe Varcasia, Rosario Foti, Valeria Riccieri, Florenzo Iannone, Alessandro Antonelli, Dilia Giuggioli, the COVID‐19 and Autoimmune Systemic Diseases Italian Study Group, Clodoveo Ferri, Vincenzo Raimondo, Dilia Giuggioli, Laura Gragnani, Serena Lorini, Lorenzo Dagna, Silvia Laura Bosello, Rosario Foti, Valeria Riccieri, Serena Guiducci, Giovanna Cuomo, Antonio Tavoni, Rossella De Angelis, Fabio Cacciapaglia, Elisabetta Zanatta, Franco Cozzi, Giuseppe Murdaca, Ilaria Cavazzana, Nicoletta Romeo, Veronica Codullo, Roberta Pellegrini, Giuseppe Varcasia, Maria De Santis, Carlo Selmi, Giuseppina Abignano, Maurizio Caminiti, Massimo L’Andolina, Domenico Olivo, Ennio Lubrano, Amelia Spinella, Federica Lumetti, Marco de Pinto, Giacomo De Luca, Veronica Batani, Piero Ruscitti, Teresa Urraro, Marcella Visentini, Silvia Bellando‐Randone, Elisa Visalli, Davide Testa, Gabriella Sciascia, Francesco Masini, Greta Pellegrino, Francesca Saccon, Eugenia Balestri, Giusy Elia, Silvia Martina Ferrari, Antonio Tonutti, Francesca Dall’Ara, Giuseppa Pagano Mariano, Giorgio Pettiti, Giovanni Zanframundo, Raffaele Brittelli, Vincenzo Aiello, Ylenia Dal Bosco, Roberta Foti, Ilenia Di Cola, Daniela Scorpiniti, Enrico Fusaro, Tommaso Ferrari, Pietro Gigliotti, Corrado Campochiaro, Francesca Francioso, Carlo Iandoli, Virginia Caira, Anna Linda Zignego, Salvatore D’Angelo, Franco Franceschini, Marco Matucci‐Cerinic, Roberto Giacomelli, Andrea Doria, Poupak Fallahi, Florenzo Iannone, Alessandro Antonelli   +95 more
wiley   +1 more source

Child-Onset Takayasu's Arteritis With Arteritic Anterior Ischemic Optic Neuropathy. [PDF]

Int J Rheum Dis
Zhao M, Li J.
europepmc   +1 more source

Anemia of Inflammation in Solid Tumor Patients and Practical Education for Oncologists and Nurses

Thoracic Cancer, Volume 17, Issue 17, September 2026.
Tumor‐ and immune‐derived cytokines including IL‐6, IL‐1β, TNF‐α, TGF‐β, IL‐10, and IFN‐γ drive anemia of inflammation: IL‐6/TNF‐α upregulate hepatic hepcidin to block iron export, while other cytokines suppress erythropoiesis and shorten red cell survival.
Xiaoyan Si, Xiaomin Wei, Xiaoyan Liu, Mei Li, Mengzhao Wang, Li Zhang   +5 more
wiley   +1 more source

Restricted cubic spline analysis of treatment duration before tocilizumab withdrawal and relapse risk in rheumatoid arthritis. [PDF]

Ther Adv Musculoskelet Dis
Jiang H, Yan Y, Zhao S, Wu R.
europepmc   +1 more source

Safety Signals of CRS and ICANS With Tarlatamab in Relapsed Small Cell Lung Cancer: Insights From a Small Case Study

Thoracic Cancer, Volume 17, Issue 18, September 2026.
In 11 patients with relapsed small cell lung cancer treated with tarlatamab, CRS occurred in 63.6% and was limited to cycle 1 day 1 or day 8; all events were Grade 1–2 and manageable without tocilizumab or treatment discontinuation. One patient developed Grade 3 ICANS and fully recovered, while NLR showed an exploratory association with CRS.
Juwhan Choi, Seunghun Lee, Sung Yong Lee
wiley   +1 more source

Clinical and laboratory manifestations and treatment of children with <i>TNFRSF1A</i> gene variants. [PDF]

World J Clin Pediatr
Alexeeva EI, Shingarova MS, Dvoryakovskaya TM, Isaeva KB, Chomakhidze AM, Fetisova AN, Chibisova KV, Krekhova EA, Kriulin IA, Kriulina TY, Tsulukiya IT, Botova MS, Kondratyeva NM, Kokina MY, Makunc AA, Dostiev NA, Savostyanov KV, Pushkov AA, Zhanin IS, Demyanov DS, Kostik MM.   +20 more
europepmc   +1 more source

A Mechanism‐Based Framework for Anti‐Aging Strategies: From Metabolic Regulation to Senotherapy and Stem Cell‐Based Interventions

Aging Cell, Volume 25, Issue 9, September 2026.
The aging of the human body is a complex process driven by multiple contributing factors. Based on their underlying mechanisms, current anti‐aging interventions can be classified into six primary categories. This paper summarizes the most promising anti‐aging strategies within each class. ABSTRACT The global prevalence of aging and age‐related diseases
Feifei Li, Yankai Wang, Gelin Wang, Jiguo Chen, Song Huang   +4 more
wiley   +1 more source

Skeletal effects of JAK1/2 inhibition versu<i>s</i> IL-6 receptor blockade in rheumatoid arthritis: a <i>post hoc</i> comparative cohort analysis based on two prospective observational studies. [PDF]

Front Pharmacol
Schulz N, van Wijnen P, Wilhelmi T, Müller-Ladner U, Lange U, Klemm P.   +5 more
europepmc   +1 more source

Recognition and management of early complications in CAR-T cell therapy and virus-specific T-lymphocyte therapy: a practical clinical reference. [PDF]

Front Immunol
Ussowicz M, Jakubczyk E, Wróbel T, Czyż A.   +3 more
europepmc   +1 more source